[go: up one dir, main page]

NO971832L - Orale formuleringer med forlenget frigivelse inneholdende cisaprid - Google Patents

Orale formuleringer med forlenget frigivelse inneholdende cisaprid

Info

Publication number
NO971832L
NO971832L NO971832A NO971832A NO971832L NO 971832 L NO971832 L NO 971832L NO 971832 A NO971832 A NO 971832A NO 971832 A NO971832 A NO 971832A NO 971832 L NO971832 L NO 971832L
Authority
NO
Norway
Prior art keywords
release formulations
formulations containing
oral extended
containing cisapride
cisapride
Prior art date
Application number
NO971832A
Other languages
English (en)
Other versions
NO312538B1 (no
NO971832D0 (no
Inventor
Eugene Marie Jozef Jans
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO971832L publication Critical patent/NO971832L/no
Publication of NO971832D0 publication Critical patent/NO971832D0/no
Publication of NO312538B1 publication Critical patent/NO312538B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cereal-Derived Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO19971832A 1994-11-02 1997-04-21 Orale formuleringer med forlenget frigivelse inneholdende cisaprid NO312538B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203184 1994-11-02
PCT/EP1995/004198 WO1996014070A1 (en) 1994-11-02 1995-10-25 Cisapride extended release oral compositions

Publications (3)

Publication Number Publication Date
NO971832L true NO971832L (no) 1997-04-21
NO971832D0 NO971832D0 (no) 1997-04-21
NO312538B1 NO312538B1 (no) 2002-05-27

Family

ID=8217338

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971832A NO312538B1 (no) 1994-11-02 1997-04-21 Orale formuleringer med forlenget frigivelse inneholdende cisaprid

Country Status (29)

Country Link
US (2) US6153623A (no)
EP (1) EP0789572A1 (no)
JP (1) JP3182423B2 (no)
KR (1) KR100255521B1 (no)
AP (1) AP658A (no)
AR (1) AR001765A1 (no)
AU (1) AU704284B2 (no)
BG (1) BG63244B1 (no)
BR (1) BR9509565A (no)
CA (1) CA2203663C (no)
CZ (1) CZ287844B6 (no)
EE (1) EE03510B1 (no)
FI (1) FI971856A7 (no)
HR (1) HRP950539A2 (no)
HU (1) HUT77887A (no)
IL (1) IL115843A0 (no)
MY (1) MY113092A (no)
NO (1) NO312538B1 (no)
NZ (1) NZ295166A (no)
OA (1) OA10419A (no)
PL (1) PL181470B1 (no)
RO (1) RO116042B1 (no)
RU (1) RU2143890C1 (no)
SK (1) SK54297A3 (no)
TR (1) TR199501351A2 (no)
TW (1) TW466114B (no)
UA (1) UA50721C2 (no)
WO (1) WO1996014070A1 (no)
ZA (1) ZA959221B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
EP0866707A1 (en) * 1995-12-01 1998-09-30 Janssen Pharmaceutica N.V. Cisapride sustained release
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
WO1998029095A2 (en) * 1997-01-03 1998-07-09 Elan Corporation, Plc Sustained release cisapride mini-tablet formulation
WO1998056364A1 (en) * 1997-06-11 1998-12-17 Janssen Pharmaceutica N.V. IMMEDIATE RELEASE pH-INDEPENDENT SOLID DOSAGE FORM OF (+)- OR (-)-CISAPRIDE
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
CO5140079A1 (es) * 1998-10-14 2002-03-22 Novartis Ag Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
HK1044715B (zh) 1999-03-31 2006-02-17 詹森药业有限公司 在控制释放制剂中的预胶凝淀粉
EP1060743A1 (en) * 1999-06-17 2000-12-20 Development Center For Biotechnology Oral cisapride dosage forms with an extended duration
RU2238087C2 (ru) * 1999-09-28 2004-10-20 Панацея Биотек Лимитед Композиции контролируемого высвобождения, содержащие нимесулид
CN1466451B (zh) * 2000-09-29 2010-05-12 索尔瓦药物有限公司 不受离子强度影响的持续释放的医药制剂
ATE408400T1 (de) * 2002-05-21 2008-10-15 Watson Lab Inc Pharmazeutische zusammensetzung mit verzögerter freisetzung
US8617596B2 (en) 2006-04-12 2013-12-31 Nippon Soda Co., Ltd. Sustained-release tablet production process
RU2356532C2 (ru) * 2007-06-01 2009-05-27 Открытое Акционерное Общество "Отечественные Лекарства" Фармацевтическая композиция проксодолола с контролируемым высвобождением
US20120065221A1 (en) 2009-02-26 2012-03-15 Theraquest Biosciences, Inc. Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
AU668386B2 (en) * 1992-03-25 1996-05-02 Depomed Systems, Incorporated Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
WO1994001112A1 (en) * 1992-07-07 1994-01-20 Sepracor Inc. Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
PL319948A1 (en) 1997-09-01
HRP950539A2 (en) 1997-08-31
AP9700969A0 (en) 1997-04-30
AR001765A1 (es) 1997-12-10
HUT77887A (hu) 1998-09-28
ZA959221B (en) 1997-04-30
NZ295166A (en) 1999-03-29
CA2203663C (en) 2002-04-30
EE9700105A (et) 1997-12-15
UA50721C2 (uk) 2002-11-15
TW466114B (en) 2001-12-01
FI971856L (fi) 1997-04-30
JP3182423B2 (ja) 2001-07-03
KR100255521B1 (ko) 2000-05-01
FI971856A0 (fi) 1997-04-30
EE03510B1 (et) 2001-10-15
OA10419A (en) 2001-12-06
IL115843A0 (en) 1996-01-31
AP658A (en) 1998-08-17
US6274599B1 (en) 2001-08-14
MX9703249A (es) 1997-07-31
CA2203663A1 (en) 1996-05-17
AU704284B2 (en) 1999-04-15
SK54297A3 (en) 1997-10-08
RU2143890C1 (ru) 2000-01-10
PL181470B1 (pl) 2001-07-31
EP0789572A1 (en) 1997-08-20
CZ124497A3 (en) 1997-08-13
FI971856A7 (fi) 1997-04-30
BG63244B1 (bg) 2001-07-31
NO312538B1 (no) 2002-05-27
JPH09511760A (ja) 1997-11-25
AU3844795A (en) 1996-05-31
US6153623A (en) 2000-11-28
BG101401A (bg) 1997-12-30
BR9509565A (pt) 1997-09-16
NO971832D0 (no) 1997-04-21
MY113092A (en) 2001-11-30
TR199501351A2 (tr) 1996-06-21
WO1996014070A1 (en) 1996-05-17
RO116042B1 (ro) 2000-10-30
CZ287844B6 (en) 2001-02-14

Similar Documents

Publication Publication Date Title
FI963421A7 (fi) Oraalisia apuainekoostumuksia
DE69518331D1 (de) Orale zubereitungen
BR9507862A (pt) Escova dental
PT769965E (pt) Formulacoes aquosas de risperidona
BR9506536A (pt) Composição oral
DE69533129D1 (de) Zahnimplantat
FI916053A7 (fi) Oraalinen koostumus hammaskiveä vastaan
FI930575L (fi) Televisionssignals underbandkoder/dekoder med olika kompatibilitetsnivaoer
FI950402A7 (fi) Oraaliset koostumukset
BR9510467A (pt) Composições orais
NO971832L (no) Orale formuleringer med forlenget frigivelse inneholdende cisaprid
BR9510307A (pt) Composições orais
ATA65293A (de) Zahnärztlicher artikulator
KR970703779A (ko) 건강 조성물(health composition)
DE69521906D1 (de) Zahnhygiene - präparate
DE59205779D1 (de) Zahnärztliches handstück
DE69432149D1 (de) Orale Zubereitungen
ATA194094A (de) Artikulator
DE69519043D1 (de) Dentalgerät
ATA183891A (de) Zahnaerztliches handstueck
ATA117494A (de) Dentales handstück
DE69420258D1 (de) Zahnimplantat
ID19099A (id) Komposisi oral
BR9510459A (pt) Composições orais
ATA65393A (de) Zahnärztlicher artikulator

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees